Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery.

ABSTRACT:

Importance

Adjuvant chemotherapy offers a survival benefit to a number of staging scenarios in non-small-cell lung cancer. Variable recovery from lung cancer surgery may delay a patient's ability to tolerate adjuvant chemotherapy, yet the urgency of chemotherapy initiation is unclear.

Objective

To assess differences in survival according to the time interval between non-small-cell lung cancer resection and the initiation of postoperative chemotherapy to determine the association between adjuvant treatment timing and efficacy.

Design, setting, and participants

This retrospective observational study examined treatment-naive patients with completely resected non-small-cell lung cancer who received postoperative multiagent chemotherapy between 18 and 127 days after resect

SUBMITTER: Salazar MC 

PROVIDER: S-EPMC5824207 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature